Eyal Herzog
Cardiovascular Disease · New York, NYNPI 1205831401
Payments from drug & device makers
$644,677in general payments, 2019–2025
Across 1,043 payments — averaging $618.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$631K
- Pfizer$12K
- C. R. Bard, Inc. & Subsidiaries$1K
- E.r. Squibb & Sons, L.L.C.$531
- AstraZeneca$76
- Nuwellis, Inc.$34
- plus $71 from 3 others
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 1,015 | $631,042 |
| Pfizer | 16 | $11,791 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $1,131 |
| E.r. Squibb & Sons, L.L.C. | 3 | $531 |
| AstraZeneca | 4 | $76 |
| Nuwellis, Inc. | 1 | $34 |
| Akcea Therapeutics, Inc. | 1 | $29 |
| Amgen | 1 | $22 |
| Cook Medical LLC | 1 | $20 |
How this compares
$644,677 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in New York
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Gregg StoneNew York$3.7M
- Valentin FusterNew York$2.9M
- Tamim NazifNew York$2.2M
- Howard WeintraubNew York$1.7M
- Anuradha Lala-TrindadeNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.